Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Leukemia|January 1, 1991
Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patientsG Cimino, S Amadori, M C Cava, et al.
Clinical and Laboratory Haematology|February 10, 1999
Red blood cell depletion of cord blood using hydroxyethylstarch double sedimentation: analysis of 40 casesG Adorno, A Bruno, T Caravita, et al.
Journal of Internal Medicine|August 1, 1997
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia veraR Stasi, M Brunetti, S Bussa, et al.
Cancer|January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin diseaseM Aglietta, F Montemurro, F Fagioli, et al.
Blood|October 1, 1982
Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemiaG V Dahl, D K Kalwinsky, S Murphy, et al.
British Journal of Haematology|December 24, 1997
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapseF Giona, A M Testi, R Rondelli, et al.
Blood|November 23, 2000
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemiaA Venditti, F Buccisano, G Del Poeta, et al.
Leukemia|September 10, 2005
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative GroupH Zwierzina, S Suciu, J Loeffler-Ragg, et al.
Current Cancer Drug Targets|May 14, 2008
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemiaG Del Poeta, A Bruno, M I Del Principe, et al.
Blood|September 9, 1999
Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantationE Abruzzese, J E Radford, J S Miller, et al.
Pageof 15